Liying Xue
Hohhot, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study.
Journal: EClinicalMedicine
Published: January 10, 2024
Erratum to 'Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas' [Journal of the National Cancer Center, 1 (2021), 4: 153-162].
Journal: Journal of the National Cancer Center
Published: December 24, 2022
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: April 20, 2022
Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas.
Journal: Journal of the National Cancer Center
Published: July 01, 2021
Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Journal: Cancer biomarkers : section A of Disease markers
Published: February 18, 2017
DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Journal: Molecular and cellular biochemistry
Published: February 07, 2017
Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway.
Journal: Experimental and therapeutic medicine
Published: December 19, 2016
HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma.
Journal: Molecular medicine reports
Published: October 30, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026